{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_dc4d9b6c3b6b513e167ec4883e8fbbe614f3340670b2d80908ca453397211c7c","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_dc4d9b6c3b6b513e167ec4883e8fbbe614f3340670b2d80908ca453397211c7c","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"7ac94d8ba1ed21675d06d7ed94234d93aec104bdef949ca86005b82821c208c1","published":"Fri, 10 Jul 2026 00:00:00 -0400","receipt_hash":"7ac94d8ba1ed21675d06d7ed94234d93aec104bdef949ca86005b82821c208c1","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"7ac94d8ba1ed21675d06d7ed94234d93aec104bdef949ca86005b82821c208c1","observed_at":"2026-07-10T04:43:53.465232Z","parent_run_hash":"06997be187ba20932a2030c56de194579eacf484085252a25bee544eab183e91","published":"Fri, 10 Jul 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2607.08602v1 Announce Type: new \nAbstract: Hepatocellular carcinoma (HCC) is a common malignancy and a leading cause of cancer-related mortality. Current guidelines and staging systems provide coarse categories, but often miss within-stage heterogeneity and the clinical context in electronic medical records (EMRs). We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model that reads routine EMR narratives and jointly outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates. We curated about 30,000 HCC cases from SEER and expanded them into EMR-style narrative training data using a clinician-validated, prompt-based augmentation workflow. On this corpus, we developed a knowledge-aligned reasoning framework optimized with a step-verifiable composite reward, moving beyond text-level memorization of clinical guidelines. In a multi-cente","title":"Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance","url":"https://arxiv.org/abs/2607.08602","vendor":"arxiv_cs_ai"},"summary":"arXiv:2607.08602v1 Announce Type: new \nAbstract: Hepatocellular carcinoma (HCC) is a common malignancy and a leading cause of cancer-related mortality. Current guidelines and staging systems provide coarse categories, but often miss within-stage heterogeneity and the clinical context in electronic medical records (EMRs). We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model that reads routine EMR narratives and jointly outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates. We curated about 30,000 HCC cases from SEER and expanded them into EMR-style narrative training data using a clinician-validated, prompt-based augmentation workflow. On this corpus, we developed a knowledge-aligned reasoning framework optimized with a step-verifiable composite reward, moving beyond text-level memorization of clinical guidelines. In a multi-cente","title":"Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-07-10T04:43:53Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2607.08602"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:e71f8826a02f70f28e6a79fa70dbce7359695127f48c7316c39a140652799fae6cad3b9f2f87e9a9224b561f1ee2169b93b72e0a65a0163e5e510411eb2bae0c","signer":"crovia.substrate","subject":{"observed_at":"2026-07-10T04:43:53Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2607.08602"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"6b03a66a432f6ec8778071ffe94415e6afb53c04540caacb517dc26c36297903","leaf_index":299398,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"3e37262351ee6e9bba0803d7063af5e783746bf1f9d710ae614f05824ce5d993","side":"right"},{"sibling":"49cf464e674ae88bea08e77623b381982eb3d723220958638c0fecdeab2df76b","side":"left"},{"sibling":"920a930f54748cb62fb60a346f3725de2c64e06f3b40d2873680dd4fc2e43caf","side":"left"},{"sibling":"06441c8e2b91c2063c9bf6518a311284066c2aee8c78c68843868be89ea0bbdf","side":"right"},{"sibling":"5caa9b6409f06ae14c82dead9e3ccc5f3bccd8af672c1014629c8f3ec7560f5c","side":"right"},{"sibling":"dd3293399a625a89daa1739bf850c981c1b380e963426dd0364a0d04169328f0","side":"right"},{"sibling":"315f14e236d484d058208a092c7e486bc56d42850a756f3d89959981a1458ce1","side":"right"},{"sibling":"b1b72243c904808d4df9b283c65832a729a411520c97fd9d17f891f214971a0a","side":"left"},{"sibling":"2c5ce75ad134aa442d7fbb5dc9968b0f2e48097c2ffaa2111d405de1c4a9c48b","side":"left"},{"sibling":"36a2c507282befad57202dd10278a66d37b402692f195a22d2275b3d1b2488d8","side":"right"},{"sibling":"f80e8d47e0860527b906fc2dba9a52609f7f623f2772479ae922cc019bab36d9","side":"right"},{"sibling":"cae83500ab2c25555aa6b5eaf9232696d15a868d91b34f7531dd955daadf70f7","side":"right"},{"sibling":"64dab64d51bdcb909e2a5e37efb8909d6704ecf824be484b5d2b60ee6e518890","side":"left"},{"sibling":"576f134a23c19a758ae5efd53016092a74b9900e878cf6eb4f3dab6be682b395","side":"right"},{"sibling":"3c65f53d7c3e4feba7c745e8df1327760ffa768eec84336db14d515a31731532","side":"right"},{"sibling":"d8b9143917b539c543cf4448cec00131f8b807bd8004979c54ebe09798748c66","side":"left"},{"sibling":"8728642cdb98496d916cc653f0d919d7eb2e89d0c529927c9e89091074ad584c","side":"right"},{"sibling":"8025674cb002a22ae243ca0c295c18c1d0ee119189ea88e08ac14a3a1468b8e3","side":"right"},{"sibling":"1cecb7f447febd025aac272837c80de218aecc6485d2395a509b2a1f1b9c746e","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":299721,"merkle_root":"f7115d63193d3285ca28cb9f741ecea2513f9b3e492e785f97076f3cf8f9bb98","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260710T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-07-10T05:38:19Z","sig_algorithm":"ed25519","signature":"4eeedeb744885bff6523d66b1cb86bde62b36917696367addfd980d90b31011daece2e01b20608e4c0870ec31dd0bcb57d297447f01f153bf0716ad527142b00","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_dc4d9b6c3b6b513e167ec4883e8fbbe614f3340670b2d80908ca453397211c7c"}}